[6] Its use for other purposes is considered investigational, and it is a legally prescribed medication
Based on the trials being conducted, retatrutide will likely be intended for: Primary target: Adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related medical comorbidity (type 2 diabetes, hypertension, sleep apnea, osteoarthritis, etc.)
Of the 42 subjects with pretreatment cyanide levels considered to be potentially toxic, 28 (67%) survived
For more detailed scientific data, you can visit PubMed to review the latest peer-reviewed literature regarding this compound
John Eng, an endocrinologist at the Bronx VA Medical Center, discovered a hormone in that venom called exendin-4
Cost and Access: What Patients Should Know Clinical trial participation in federally funded or major foundation-sponsored trials such as PROTECT-Cog is typically provided at no cost to participants